Reprogramming the Tumor: Lew Bender on Engineering a New Paradigm in Cancer Therapy

From a basement-born idea to a publicly traded biotech advancing late-stage clinical trials, Lew Bender’s journey reflects both scientific persistenc...

April 02, 2026 | Thursday | Interaction
Thermo Fisher Scientific Launches Next-Generation CHOvantage™ GS Platform to Accelerate Biologics Development Timelines

Thermo Fisher Scientific Inc., the world leader in serving science,  announced a next-generation, integrated cell line development platform that ena...

April 02, 2026 | Thursday | News
AskBio Completes Enrollment In GenePHIT Phase 2 Trial For AB 1002 In Heart Failure

Final participant randomized in the GenePHIT Phase 2 clinical trial assessing safety and efficacy of AB-1002 for adults with non-ischemic cardiomyopath...

April 02, 2026 | Thursday | News
Samsung Biologics Secures GSK Site in $Capacity Boost to 845,000L

  Adds 60,000 liters of drug substance capacity, bringing the total to 845,000 liters Marks Samsung Biologics’ geographical diversific...

April 01, 2026 | Wednesday | News
Galapagos Partners with Gilead to Advance T Cell Engager Gamgertamig in Autoimmune Diseases

New collaboration structure achieves meaningfully improved financial terms and flexibility for Galapagos  Following this transaction, the Company w...

April 01, 2026 | Wednesday | News
Avacta Doses First Patient in FOCUS-01 Trial of AVA6103, Advancing Tumor-Targeted Oncology Platform

Enrollment underway in second Avacta clinical program at first three specialist U.S. oncology centers Initial data from the trial expected later this ye...

April 01, 2026 | Wednesday | News
Biogen to Acquire Apellis in $5.6B Deal to Strengthen Immunology and Rare Disease Portfolio

Acquisition will bring two differentiated commercialized immunology medicines to Biogen with EMPAVELI® FDA-approved in three indications, including...

April 01, 2026 | Wednesday | News
Biomea Advances Icovamenib into Phase II With Dual COVALENT Studies in Type 2 Diabetes

COVALENT-211 Phase II enrolling insulin-deficient type 2 diabetes patients COVALENT-212 Phase II enrolling type 2 diabetes patients uncontrolled wit...

April 01, 2026 | Wednesday | News
Nuclera Expands eProtein Discovery Platform with GPCR Nanodisc Panel

Enables expression of active GPCRs in 48 hours Panel supports screening to scale-up on eProtein Discovery Nuclera, the biotechnology comp...

March 31, 2026 | Tuesday | News
Otsuka Pharmaceutical Co., Ltd. to Acquire Transcend Therapeutics, Inc. in $1.2 Billion Deal to Advance Next-Generation PTSD Therapies

Expands Otsuka portfolio in psychiatric and neurological fields and aims to accelerate development of Transcend's portfolio, including the TSND-201 progr...

March 30, 2026 | Monday | News
Mayo Clinic Secures $75 Million Grainger Family Gift to Power Next-Generation Healthcare Campus

Mayo Clinic announces a gift of $75 million from the Thomas and Elizabeth Grainger family to support Bold. Forward. Unbound. in Rochester, Mayo Clinic's ...

March 30, 2026 | Monday | News
Eli Lilly and Company Showcases Dual-Therapy Breakthrough in Psoriatic Arthritis and Obesity at AAD 2026

Eli Lilly and Company announced detailed results from the TOGETHER-PsA open-label Phase 3b clinical trial evaluating the concomitant use of Taltz (ixekiz...

March 30, 2026 | Monday | News
Thermo Fisher Expands U.S. Sterile Manufacturing Footprint with SHL Medical Collaboration for Integrated Autoinjector Solutions

Thermo Fisher Scientific Inc., the world leader in serving science, announced a strategic collaboration with SHL Medical, a leading provider of advance...

March 27, 2026 | Friday | News
Verana Health and Guardant Health Partner to Advance Real-World Clinicogenomic Data for Cancer Research

 Verana Health®, a digital health company dedicated to revolutionizing patient care and clinical research through real-world data (RWD), has ann...

March 26, 2026 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close